Q3 2022 Holdings
Filed 2022-11-14 | 87 holdings | $52.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $14.0M | 135,712 | 26.7% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $8.9M | 183,995 | 17.0% |
| Alector Inc(ALEC) | COM | 014442107 | $5.0M | 532,438 | 9.6% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $4.7M | 475,367 | 9.0% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $4.7M | 178,717 | 8.9% |
| Axogen Inc(AXGN) | COM | 05463X106 | $4.0M | 332,103 | 7.5% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $2.8M | 122,200 | 5.4% |
| Atricure Inc(ATRC) | COM | 04963C209 | $2.8M | 72,029 | 5.4% |
| Accuray Inc(ARAY) | COM | 004397105 | $2.0M | 941,800 | 3.7% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $1.1M | 496,150 | 2.0% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $530.0K | 313,600 | 1.0% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $508.0K | 47,390 | 1.0% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $429.0K | 188,094 | 0.8% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $377.0K | 351,064 | 0.7% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $339.0K | 34,625 | 0.6% |
| Spdr SP Biotech ETF(XBI) | ETF | 78464A870 | $44.9K | 566,000 | 0.1% |
| Stereotaxis Inc(STXS) | COM NEW | 85916J409 | $24.6K | 13,680,554 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $17.2K | 261,235 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $16.6K | 110,100 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $13.5K | 375,223 | 0.0% |
| Adicet BIO Inc(TORCEUR) | COM | 007002108 | $13.3K | 935,766 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $12.1K | 539,940 | 0.0% |
| Ishares TR Nasdaq Biotech Indx(IBB) | ETF | 464287556 | $12.0K | 102,500 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $9.5K | 479,785 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $8.5K | 355,487 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $8.5K | 80,155 | 0.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $8.0K | 538,561 | 0.0% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $7.7K | 781,112 | 0.0% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $7.4K | 566,695 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $7.2K | 401,476 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $7.1K | 180,306 | 0.0% |
| Karuna Therapeutics Inc | COM | 48576A100 | $6.5K | 28,886 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $6.0K | 1,703,235 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $5.8K | 72,552 | 0.0% |
| Merus N V | COM | N5749R100 | $5.5K | 276,893 | 0.0% |
| Morphic Hldg Inc | COM | 61775R105 | $5.5K | 195,467 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $5.0K | 71,600 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $4.6K | 307,232 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $4.5K | 65,946 | 0.0% |
| Cardiovascular SYS Inc(CSIIEUR) | COM | 141619106 | $4.0K | 286,988 | 0.0% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $3.8K | 654,862 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $3.7K | 255,313 | 0.0% |
| F-Star Therapeutics Inc | COM | 30315R107 | $3.0K | 576,881 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $2.8K | 206,329 | 0.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $2.6K | 377,763 | 0.0% |
| Mediwound LTD | ORD SHS | M68830104 | $2.0K | 1,428,571 | 0.0% |
| Vigil Neuroscience Inc(VIGL) | COM | 92673K108 | $2.0K | 216,395 | 0.0% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $1.9K | 97,560 | 0.0% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $1.8K | 574,996 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $1.8K | 42,675 | 0.0% |